Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2.
    Difference
    0.5%
    Check dated 2025-11-24T20:52:39.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Standardized the Taiwan site name by replacing 'Tainan City, Taiwan' with 'Tainan, Taiwan' in the locations section.
    Difference
    0.3%
    Check dated 2025-11-17T18:11:16.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Minor UI updates and timestamp changes observed; core study details remain unchanged, To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:48:59.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Added a government funding notice and a v3.2.0 revision tag; removed the previous v3.1.0 tag. If any time-sensitive content (operating status) is now present, it should be considered updated.
    Difference
    3%
    Check dated 2025-10-05T17:39:40.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T11:15:23.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Updated the revision to v3.0.2 and removed the Back to Top element. No core content, pricing, stock, or time-slot information was affected.
    Difference
    0.2%
    Check dated 2025-09-14T00:40:41.000Z thumbnail image

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.